3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
2
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
61
Stomach Neoplasms
27
Rectal Neoplasms
20
Colonic Neoplasms
19
Small Cell Lung Carcinoma
12
Pancreatic Neoplasms
11
Neoplasm Metastasis
11
Locally Advanced Rectal Cancer
5
Colorectal Cancer Metastatic
5
Esophageal Squamous Cell Carcinoma
4
Esophageal Neoplasms
4
Biliary Tract Neoplasms
4
Recurrence
3
Liver Neoplasms
3
Glioblastoma
3
Gastrointestinal Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Solid Tumors
2
Sarcoma
2
Lung Neoplasms
2
Glioma
2
Gallbladder Neoplasms
2
Advanced Gastric Cancer Adenocarcinoma of Esophagogastric Junction
2
Advanced Colorectal Cancer
2
mCRC
1
Unspecified Adult Solid Tumor, Protocol Specific
1
Thrombocytopenia
1
Second Line Treatment of Gastric Cancer
1
Interventions
Oxaliplatin
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Metastatic Pancreatic Adenocarcinoma
×
Irinotecan
×
Clear all
NCT01729481
2017-07-19
ML22774
Ludwig-Maximilians - University of Munich
Phase 2
Unknown
150 enrolled